South Korea Car-T Cell Therapy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

South Korea Car-T Cell Therapy Market is Segmented By Targeted Antigen (CD19, CD20, BCMA, GCP-3, Claudin 18.2), By Therapeutic Application (B-cell non-Hodgkin\'s lymphoma, Multiple Myeloma, Cervical Cancer, Gastric Cancer, Lung Cancer, Others). The report offers the value (in USD Million) for the above-mentioned segments

South Korea Car-T Cell Therapy Market Leaders

  • Novartis AG
  • Pfizer, Inc.
  • Bristol Myers Squibb
  • CARsgen Therapeutics Co., Ltd.
  • Fate Therapeutics, Inc.
*Disclaimer: Major players are listed in no particular order.

South Korea Car-T Cell Therapy Market - Company List

  • Novartis AG
  • Pfizer, Inc.
  • Bristol Myers Squibb
  • CARsgen Therapeutics Co., Ltd.
  • Fate Therapeutics, Inc.
  • Poseida Therapeutics, Inc.
  • Eureka Therapeutics, Inc.
  • Johnson & Johnson
  • Cellular Biomedicine Group
  • Gilead Sciences, Inc.

South Korea Car-T Cell Therapy Market Report Snapshots

Buy Now